Clinical Research Directory

Inclusion Criteria: * Adult patients (≥18 years) with a confirmed diagnosis of HCC based on AASLD or EASL criteria. * Patients deemed unresectable by the multidisciplinary tumor board. * Patients scheduled for TACE as the primary locoregional therapy. * Preserved liver function (Child-Pugh class A or B). * Adequate renal function to permit contrast-enhanced CT. Exclusion Criteria: * Patients with extrahepatic metastases or portal vein thrombosis. * Patients with contraindications to iodinated contrast or TACE. * Patients with severe comorbid illness that precludes participation. * Patients refuse to provide informed consent.